메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
한국임상약학회 한국임상약학회지 한국임상약학회지 제17권 제2호
발행연도
2007.1
수록면
109 - 116 (8page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
The carbapenem class such as imipenem (as I), meropenem (as M), and ertapenem(as E), is the most potent and widest spectrum of antimicrobial activity among many structurally distinct β-lactams. The aim of this study is comparatively to evaluate for imipenem, meropenem, versus ertapenem for various infections in a community hospital. This study was performed retrospectively on total 250 cases with I(153), M(88) or E(9) for longer than 3 continuous days at Chungbuk National University Hospital from January 1st thru December 31st, 2005. The major treating microorganisms were E. coli (16.0%), K. pneumoniae (16.0%), A. calcoaceticus-baumannii complex (12.6%), P. aeruginosa (12.0 %) and others (less than 10%), etc. Major diagnoses were sepsis (I26.8%, M63.6% and E33.3%), pneumonia (I35.3% and M13.6%), and intra-abdominal infections (I18.3% and E66.7%), etc and I(5), M(5), and E(4) cases were not met the criteria based on the culture results. In carbapenem monotherapy, the efficacy was I37.3% and M33.0%. All dosage were also appropriate. The mean durations of therapy were all within 14 days. Adverse drug reactions were reported for total 25 cases such as seizure (I4 and M7) or diarrhea (I8, M5, and E1) cases. Uses of carbapenem for inpatient infections were appropriate according to this study and will be recommended in the future.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0